US Forming Industry Consortia To Prepare For Future Pandemics And Global Supply Chain Disruptions
Executive Summary
HHS agencies look to build on COVID-19 experience by developing quicker public/private responses to pandemics and supply chain threats.
You may also be interested in...
Brookings’ Drug Shortages Remedies Target Both Hospitals And Manufacturers
Incentives would give hospitals reason to pay for quality and reliability, while loans would help generics manufacturers upgrade sterile injectables facilities and feds would buffer supply chains with additional inventories, the policy think tank says. All it would take is an act of Congress.
Supply Chain Conversations Should Continue, But Industry Wants More Government Transparency
Healthcare Distribution Alliance CEO Chip Davis says drug wholesalers and suppliers need the government’s information on product demand, just as the government needs industry inventory data, to anticipate and avert shortages.
US FDA Looks To Resume Unannounced Inspections In India And China
After lapsing due to COVID-19, an unannounced foreign inspection pilot program is on track to resume in 2022, “despite challenges and constraints of travel.”